Differential effect of body mass index on pediatric heart transplant outcomes based on diagnosis

Justin Godown1, Janet E Donohue, Sunkyung Yu

  • 1Division of Pediatric Cardiology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, USA.

Insights

Nutritional status impacts pediatric heart transplant (HTx) waitlist mortality differently based on diagnosis. Extremely high or low body mass index (BMI) increases waitlist mortality risk in congenital malformation (CM) patients, but not congenital heart disease (CHD) patients.

Area of Science:

  • Pediatric Cardiology
  • Transplant Surgery
  • Nutritional Science

Background:

  • The influence of nutritional status on pediatric heart transplant (HTx) waitlist and post-transplant survival remains unclear.
  • Existing data on nutrition's role in post-HTx outcomes are conflicting.

Purpose of the Study:

  • To investigate the impact of nutritional status, specifically body mass index (BMI) percentile, on waitlist and post-HTx outcomes in pediatric patients.
  • To determine if BMI influences mortality risk before and after heart transplantation in children.

Main Methods:

  • Retrospective analysis of 2712 children (2-18 years) listed for HTx between 1997 and 2011 from the OPTN database.
  • Patients were stratified by BMI percentile.
  • Multivariable logistic regression and Cox proportional hazard regression were used to assess the impact of BMI on waitlist and post-HTx mortality, respectively.

Main Results:

  • Overall, BMI did not significantly impact waitlist, one-year, or five-year post-HTx mortality.
  • However, in patients with congenital malformations (CM), BMI > 95th percentile and BMI < 1st percentile were independent risk factors for waitlist mortality.
  • BMI did not affect waitlist mortality in patients with congenital heart disease (CHD) or post-HTx outcomes for either diagnosis.

Conclusions:

  • Nutritional status, indicated by extreme BMI percentiles, presents differential risks for waitlist mortality in pediatric heart transplant candidates based on underlying diagnosis.
  • Very high or very low BMI is a significant risk factor for waitlist mortality in pediatric patients with congenital malformations (CM), but not congenital heart disease (CHD).
  • These findings suggest that an individualized approach to risk assessment and nutritional management, considering the specific disease etiology, is warranted for pediatric HTx candidates.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
821
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
364
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K